14-93721473-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_178013.4(PRIMA1):c.433G>A(p.Gly145Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178013.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRIMA1 | NM_178013.4 | c.433G>A | p.Gly145Arg | missense_variant | 5/5 | ENST00000393140.6 | NP_821092.1 | |
PRIMA1 | XM_011536456.3 | c.433G>A | p.Gly145Arg | missense_variant | 5/5 | XP_011534758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRIMA1 | ENST00000393140.6 | c.433G>A | p.Gly145Arg | missense_variant | 5/5 | 1 | NM_178013.4 | ENSP00000376848 | P1 | |
PRIMA1 | ENST00000393143.5 | c.433G>A | p.Gly145Arg | missense_variant | 4/4 | 1 | ENSP00000376851 | P1 | ||
PRIMA1 | ENST00000316227.3 | c.*229G>A | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000320948 | ||||
PRIMA1 | ENST00000477603.5 | c.*229G>A | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 1 | ENSP00000434370 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251256Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135792
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461508Hom.: 0 Cov.: 28 AF XY: 0.00000825 AC XY: 6AN XY: 727076
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Sleep-related hypermotor epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2021 | This sequence change replaces glycine with arginine at codon 145 of the PRIMA1 protein (p.Gly145Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is present in population databases (rs779293897, ExAC 0.05%). This variant has not been reported in the literature in individuals affected with PRIMA1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at